Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Migraine with Brainstem Aura (MBA) market involves treating people with headaches that are linked to the brainstem to understand and treat their symptoms. The process of identifying people, giving them treatments, and taking care of them is a lot harder with this one-of-a-kind form.
Before you can learn more about the market, you should first learn about the signs of an MBA. Some of these signs are trouble seeing, feeling dizzy, having trouble speaking, and having trouble synchronizing your movements. It is important for experts to set MBAs apart in a way that makes sense when compared to other types of headaches and brain problems. These results show how important it is to use testing methods that are both accurate and very specific.
To be able to change to changing market conditions, you need to have a good understanding of MBA influence. Even though people who get this type of migraine are pretty rare, the strong and complicated symptoms they experience have a huge effect on those who have it. If you know how often it happens, you can better plan your healthcare and share resources with other people.
The market is changed by the changes that were made to the MBA handling policy. Certain medicines, like antiemetics, triptans, and nonsteroidal anti-inflammatory drugs (NSAIDs), may be recommended for more serious cases. For example, new ideas from experts in the field, new findings from study, and how patients respond to treatment are all things that could change the market. You can also choose to take drugs that keep you from getting sick.
One of the skills that are sought after in the competitive MBA market is the ability to understand how important things affect day-to-day work. There is a chance that feeling dizzy and having trouble speaking could make it hard to work, do well in school, and connect with other people. To help people in MBA programs improve their quality of life, they need personalized care plans.
According to market research, new ideas and ongoing studies are good because they help find treatment goals and gain a better understanding of how MBA works. Some of the information that might help make new medicines and treatments better comes from clinical trials and research studies. That means the answers are more focused and useful, which is what we can say.Market drivers include MBA awareness and assistance by patient aid organizations. These organizations shape healthcare legislation, fund research, and advocate for patient-centered treatment, helping individuals with this form of migraine manage their issues.
Neurologists, headache specialists, and general practitioners influence markets. Doctors must stay abreast of new diagnostic criteria, treatment options, and research to improve patient outcomes.
Recognition and treatment of MBA-related issues including mental disorders and heart disease are crucial to market dynamics. MBA patients require holistic treatment to control their illness.
Global market trends, healthcare facilities, professional care, and culture all matter. These patterns and characteristics must be understood by pharmaceutical companies, healthcare personnel, and policymakers to create policies that address MBA issues in particular locations.
Migraine Brainstem Aura Market Highlights:
Migraine with Brainstem Aura Market Overview
Migraine with Brainstem Aura Market Size was valued at USD 6.21 Billion in 2023. The Migraine with Brainstem Aura industry is projected to grow from USD 6.95 Billion in 2024 to USD 10.64 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.48% during the forecast period (2024 - 2032). A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occur in men and women of all ages.
The symptoms of this migraine include visual disturbances in both eyes, vertigo, hearing problems, nausea, dizziness among others. A migraine with brainstem aura (MBA) may affect one or both the sides of the brain. This rare migraine may be caused by a constriction of blood vessels that limit the blood flow to the brain. Moreover, certain external factors such as stress, motion sickness, epilepsy, alcoholism, prolonged hunger, excessive use of headache medications can trigger basilar artery migraines.
The factors such as rising prevalence of a migraine and growing awareness about rare types of migraines in the developed economies are major drivers for the market growth. In addition, the rising need for better treatment approaches, increasing investment of biotechnology and pharmaceutical industries in research & development (R&D) are expected to contribute to the growth of the market. However, side effects associated with migraine treatment drugs may hamper the growth of the market during the forecast period.
Migraine with Brainstem Aura Market Segmentation
The migraine with brainstem aura market has been segmented into diagnosis, treatment, distribution channel, and end-user.
The market, by diagnosis, has been segmented into magnetic resonance imaging (MRI), computerized tomography (CT), and others.
The market, on the basis of treatment, has been segmented into abortive medication and preventive medication. The abortive medication segment has been segmented into non-steroidal anti-inflammatory drugs (NSAIDs), anti-nausea medications, and others. The preventive medication segment has been further segmented into botox injections, antidepressants, and others.
On the basis of the distribution channel, the market has been segmented into retail pharmacies, hospital pharmacies, and others.
The market, by end-user, has been segmented into hospital & clinics, diagnostic centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The migraine with brainstem aura market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European migraine with brainstem aura market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The migraine with brainstem aura market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The migraine with brainstem aura market in the Middle East & Africa has been segmented into the Middle East and Africa.
Migraine with Brainstem Aura Market Key Players
Some of the key players in the global market are:
- Allergen Plc
- Merck & Co., Inc.
- Pfizer, Inc.
- GlaxoSmithKline Plc
- Abbott Laboratories
- AstraZeneca, Eisai Co., Ltd.
- Endo International Plc
- Impax Laboratories
- Eli Lily and Company
- and Johnson & Johnson
Migraine with Brainstem Aura Market Regional Analysis
Geographically, the Americas is anticipated to dominate the migraine with brainstem aura market owing to a well-developed healthcare sector, rising prevalence of migraine and growing healthcare expenditure. According to the Centers for Disease Control and Prevention (CDC), in 2015, 20% of women and 9.7% of men aged 18 or more had a migraine. Additionally, the large number of research and development (R&D) activities contributes to the growth of the market.
Europe is expected to hold the second largest position in the migraine with brainstem aura. The market growth in this region is attributed to the availability of funds for research, growing prevalence of migraine, and increasing healthcare expenditure. According to the World Health Organization (WHO), it is estimated that around 1 in 7 people in the UK experience migraine. It also stated that there are around 190,000 migraine attacks in the UK.
The migraine with brainstem aura market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in the market due to continuously developing economies, rising prevalence of migraine and increasing government funding for the healthcare sector.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Migraine with Brainstem Aura Market, by Diagnosis
- Magnetic Resonance Imaging (MRI)
- Computerized Tomography (CT)
- Others
Migraine with Brainstem Aura Market, by Treatment
- Abortive Medication
- Non-steroidal anti-inflammatory drugs (NSAIDS)
- Ibuprofen
- Others
- Anti-nausea Medications
- Preventive Medication
- Botox Injections
- Antidepressants
- Others
Migraine with Brainstem Aura Market, by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Others
Migraine with Brainstem Aura Market, by End-User
- Hospital & Clinics
- Diagnostic Centers
- Others
Migraine with Brainstem Aura Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
